Menu

Blog

Page 3666

Sep 1, 2022

A novel injection therapy could restore cognitive function in people with Down syndrome

Posted by in categories: biotech/medical, neuroscience

The promising results led to improved not only cognitive function but also brain connectivity.

An Inserm team at the Lille Neuroscience & Cognition laboratory is working with scientists at Lausanne University Hospital to evaluate the effectiveness of GnRH injection therapy in enhancing cognitive functions in a small group of Down syndrome patients, according to a press release published on Eurekalert.

Down syndrome is the most common chromosomal condition in the United States. According to the Centers for Disease Control and Prevention, about one in every 6,000 babies born in the U.S. has Down syndrome. It causes various symptoms, such as deterioration in cognitive capacity.

Sep 1, 2022

Bridge centrality network structure of negative symptoms in people with schizophrenia

Posted by in category: neuroscience

Negative symptoms are complex psychopathology. Although evidence generally supported the NIMH five consensus domains, research seldom examined measurement invariance of this model, and domain-specific correspondence across multiple scales. This study aimed to examine the interrelationship between negative symptom domains captured by different rating scales, and to examine the domain-specific correspondence across multiple scales. We administered the Brief Negative Symptom Scale (BNSS), the Self-evaluation of Negative Symptoms (SNS), and the Scale for Assessment of Negative Symptoms (SANS) to 204 individuals with schizophrenia. We used network analysis to examine the interrelationship between negative symptom domains.

Sep 1, 2022

Fentanyl’s Effects on the Brain

Posted by in categories: biotech/medical, neuroscience

Summary: Fentanyl exposure produces specific EEG signatures in the brain. The findings also revealed the drug impairs people’s breathing four minutes before noticeable changes in alertness.

Source: Mass General.

Fentanyl is used to supplement sedation and to relieve severe pain during and after surgery, but it’s also one of the deadliest drugs of the opioid epidemic.

Sep 1, 2022

Alzheimer’s Breakthrough: Genetic Link to Gut Disorders Confirmed

Posted by in categories: biotech/medical, genetics, neuroscience

Summary: A new study reveals a genetic link between Alzheimer’s disease and several gut-related disorders. Researchers report Alzheimer’s patients and those with intestinal disorders have specific genes in common. The findings add to the evidence the gut-brain axis may play a role in the development of neurodegenerative disorders.

Source: Edith Cowan University.

People with gut disorders may be at greater risk of developing Alzheimer’s Disease (AD).

Sep 1, 2022

How a Brain Area Implicated in Alzheimer’s May Be Vulnerable to Degeneration

Posted by in categories: biotech/medical, neuroscience

Summary: Study reveals a novel mechanism in locus coeruleus neurons caused by the loss of the GPT2 mitochondrial enzyme that is implicated in the development and progression of neurodegenerative diseases.

Source: Brown University.

The locus coeruleus is among the first brain regions to degenerate in Alzheimer’s and Parkinson’s disease, physicians and scientists have known. But why this area is so vulnerable is less understood.

Sep 1, 2022

Scientists Enable a Blind Woman to See Simple Shapes

Posted by in categories: biotech/medical, cyborgs

Summary: Researchers created a form of artificial vision for a blind woman with the aid of a brain implant position in the visual cortex. The results pave the way for the creation of visual brain prosthetics to help the blind to regain sight.

Source: KNAW

Newly published research details how a team of scientists from the University Miguel Hernández (Spain), the Netherlands Institute of Neuroscience (Netherlands) and the John A. Moran Eye Center at the University of Utah (USA) successfully created a form of artificial vision for a blind woman using a brain implant.

Sep 1, 2022

How People Adapt to Cybersickness From Virtual Reality

Posted by in categories: entertainment, military, virtual reality

Summary: Those who are prone to motion sickness have a harder time adapting to cybersickness and different virtual reality environments. However, people can adapt to the effects of VR-associated cybersickness by playing the same game repeatedly.

Source: Iowa State University

While virtual reality has been around for decades, a combination of higher-resolution graphics, smoother tracking of the user’s movements and cheaper, sleeker headsets has propelled the immersive technology into arenas beyond gaming and military training.

Sep 1, 2022

Bioengineered Cornea Can Restore Sight to the Blind and Visually Impaired

Posted by in categories: bioengineering, biotech/medical

Summary: Researchers have developed a cornea implant from the collagen protein of pig skin. The implant restored the vision of 20 people with diseased corneas. The new implant could be a viable alternative to human cornea transplantation.

Source: Linkoping University.

Researchers and entrepreneurs have developed an implant made of collagen protein from pig’s skin, which resembles the human cornea. In a pilot study, the implant restored vision to 20 people with diseased corneas, most of whom were blind prior to receiving the implant.

Sep 1, 2022

Can We Reverse the Effects of Age Related Memory Loss? Experts Say Yes

Posted by in categories: biotech/medical, neuroscience

Summary: A 20-minute session of non-invasive brain stimulation over four days helps to improve both working and long-term memory in those aged 65 and older.

Source: Boston University.

According to the Alzheimer’s Association, an estimated 6.5 million Americans aged 65 and older are living with Alzheimer’s in 2022. That figure is predicted to nearly double by 2050.

Sep 1, 2022

Glycerol-3-phosphate shuttle is a backup system securing metabolic flexibility in neurons

Posted by in categories: biotech/medical, neuroscience, sex

Electrical activity in neurons is highly energy demanding and accompanied by rises in cytosolic Ca2+. Cytosolic Ca2+, in turn, secures energy supply by pushing mitochondrial metabolism either through augmented NADH transfer into mitochondria via the malate aspartate shuttle (MAS) or via direct activation of dehydrogenases of the TCA cycle after passing into the matrix through the mitochondrial Ca2+ uniporter (MCU). Another Ca2+-sensitive booster of mitochondrial ATP synthesis is the glycerol-3-phosphate shuttle (G3PS) whose role in neuronal energy supply has remained elusive. Essential components of G3PS are expressed in hippocampal neurons. Single neuron metabolic measurements in primary hippocampal cultures derived from rat pups of either sex reveal only moderate, if any, constitutive activity of G3PS. However, during electrical activity neurons fully rely on G3PS when MAS and MCU are unavailable. Under these conditions, G3PS is required for appropriate action potential firing. Accordingly, G3PS safeguards metabolic flexibility of neurons to cope with energy demands of electrical signaling.

SIGNIFICANCE STATEMENT:

Ca2+ ions are known to provide a link between the energy-demanding electrical activity and an adequate ATP supply in neurons. To do so, Ca2+ acts both, from outside and inside of the mitochondrial inner membrane. Neuronal function critically depend on this regulation and its defects are often found in various neurological disorders. Although interest in neuronal metabolism increases, many aspects thereof have remained unresolved. In particular, a Ca2+-sensitive NADH shuttling system, the glycerol-3-phosphate shuttle, has been largely ignored with respect to its function in neurons. Our results demonstrate that this shuttle is functional in hippocampal neurons and safeguards ATP supply and appropriate action potential firing when malate aspartate shuttle and mitochondrial Ca2+ uniporter are unavailable, thereby ensuring neuronal metabolic flexibility.